{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:57:16Z","timestamp":1776722236290,"version":"3.51.2"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s40272-014-0065-5","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T09:18:49Z","timestamp":1393406329000},"page":"199-211","source":"Crossref","is-referenced-by-count":31,"title":["The Delayed-Release Combination of Doxylamine and Pyridoxine (Diclegis\u00ae\/Diclectin\u00ae) for the Treatment of Nausea and Vomiting of Pregnancy"],"prefix":"10.1007","volume":"16","author":[{"given":"Svetlana","family":"Madjunkova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Maltepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"key":"65_CR1","doi-asserted-by":"crossref","unstructured":"Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182(4):931\u20137.","DOI":"10.1016\/S0002-9378(00)70349-8"},{"issue":"10","key":"65_CR2","first-page":"24","volume":"252676","author":"SM Clark","year":"2012","unstructured":"Clark SM, Costantine MM, Hankins GD. Review of NVP and HG and early pharmacotherapeutic intervention. Obstet Gynecol Int. 2012;252676(10):24.","journal-title":"Obstet Gynecol Int."},{"key":"65_CR3","unstructured":"APGO. Nausea and vomiting of pregnancy. APGO Educational series on women\u2019s health issues. Boston: Jespersen & Associates, LLC; 2013."},{"issue":"3","key":"65_CR4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ogc.2008.04.002","volume":"35","author":"TM Goodwin","year":"2008","unstructured":"Goodwin TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am. 2008;35(3):401\u201317.","journal-title":"Obstet Gynecol Clin North Am."},{"issue":"4","key":"65_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF02718384","volume":"251","author":"AE Czeizel","year":"1992","unstructured":"Czeizel AE, Dudas I, Fritz G, Tecsoi A, Hanck A, Kunovits G. The effect of periconceptional multivitamin-mineral supplementation on vertigo, nausea and vomiting in the first trimester of pregnancy. Arch Gynecol Obstet. 1992;251(4):181\u20135.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"65_CR6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/01443610410001722581","volume":"24","author":"G Koren","year":"2004","unstructured":"Koren G, Maltepe C. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. J Obstet Gynaecol. 2004;24(5):530\u20133.","journal-title":"J Obstet Gynaecol."},{"issue":"4","key":"65_CR7","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bpobgyn.2008.12.012","volume":"23","author":"C Bottomley","year":"2009","unstructured":"Bottomley C, Bourne T. Management strategies for hyperemesis. Best Pract Res Clin Obstet Gynaecol. 2009;23(4):549\u201364.","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"issue":"5","key":"65_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humupd\/dmi021","volume":"11","author":"MF Verberg","year":"2005","unstructured":"Verberg MF, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11(5):527\u201339.","journal-title":"Hum Reprod Update."},{"issue":"46","key":"65_CR9","first-page":"1741","volume":"8","author":"JK Jueckstock","year":"2010","unstructured":"Jueckstock JK, Kaestner R, Mylonas I. Managing hyperemesis gravidarum: a multimodal challenge. BMC Med. 2010;8(46):1741\u20137015.","journal-title":"BMC Med."},{"key":"65_CR10","doi-asserted-by":"crossref","unstructured":"Koch KL. Gastrointestinal factors in nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S198\u2013203.","DOI":"10.1067\/mob.2002.122598"},{"issue":"1","key":"65_CR11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0889-8553(02)00070-5","volume":"32","author":"KL Koch","year":"2003","unstructured":"Koch KL, Frissora CL. Nausea and vomiting during pregnancy. Gastroenterol Clin North Am. 2003;32(1):201\u201334.","journal-title":"Gastroenterol Clin North Am."},{"key":"65_CR12","doi-asserted-by":"crossref","unstructured":"Nguyen P, Einarson A. Managing nausea and vomiting of pregnancy with pharmacological and nonpharmacological treatments. Women\u2019s health (London, England). 2006;2(5):753\u201360. doi: 10.2217\/17455057.2.5.753 .","DOI":"10.2217\/17455057.2.5.753"},{"issue":"4","key":"65_CR13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1155\/2009\/678514","volume":"23","author":"SK Gill","year":"2009","unstructured":"Gill SK, Maltepe C, Koren G. The effect of heartburn and acid reflux on the severity of nausea and vomiting of pregnancy. Can J Gastroenterol. 2009;23(4):270\u20132.","journal-title":"Can J Gastroenterol."},{"issue":"3","key":"65_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/01.AOG.0000278571.93861.26","volume":"110","author":"D Golberg","year":"2007","unstructured":"Golberg D, Szilagyi A, Graves L. Hyperemesis gravidarum and Helicobacter pylori infection: a systematic review. Obstet Gynecol. 2007;110(3):695\u2013703.","journal-title":"Obstet Gynecol."},{"issue":"11","key":"65_CR15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3109\/00016340903284927","volume":"88","author":"I Sandven","year":"2009","unstructured":"Sandven I, Abdelnoor M, Nesheim BI, Melby KK. Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case\u2013control studies. Acta Obstet Gynecol Scand. 2009;88(11):1190\u2013200.","journal-title":"Acta Obstet Gynecol Scand."},{"issue":"1","key":"65_CR16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejogrb.2012.11.007","volume":"167","author":"AV Vikanes","year":"2013","unstructured":"Vikanes AV, Stoer NC, Gunnes N, Grjibovski AM, Samuelsen SO, Magnus P, et al. Helicobacter pylori infection and severe hyperemesis gravidarum among immigrant women in Norway: a case\u2013control study. Eur J Obstet Gynecol Reprod Biol. 2013;167(1):41\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"65_CR17","doi-asserted-by":"crossref","unstructured":"Sherman PW, Flaxman SM. Nausea and vomiting of pregnancy in an evolutionary perspective. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S190\u20137.","DOI":"10.1067\/mob.2002.122593"},{"issue":"2","key":"65_CR18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1542-2011.2010.00019.x","volume":"56","author":"MS Fejzo","year":"2011","unstructured":"Fejzo MS, Macgibbon KW, Romero R, Goodwin TM, Mullin PM. Recurrence risk of hyperemesis gravidarum. J Midwifery Womens Health. 2011;56(2):132\u20136. doi: 10.1111\/j.1542-2011.2010.00019.x .","journal-title":"J Midwifery Womens Health."},{"issue":"1","key":"65_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejogrb.2008.07.003","volume":"141","author":"MS Fejzo","year":"2008","unstructured":"Fejzo MS, Ingles SA, Wilson M, Wang W, MacGibbon K, Romero R, et al. High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals. Eur J Obstet Gynecol Reprod Biol. 2008;141(1):13\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"65_CR20","doi-asserted-by":"crossref","unstructured":"Attard CL, Kohli MA, Coleman S, Bradley C, Hux M, Atanackovic G, et al. The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S220\u20137.","DOI":"10.1067\/mob.2002.122605"},{"issue":"12","key":"65_CR21","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1471-0528.2008.01891.x","volume":"115","author":"A Lacasse","year":"2008","unstructured":"Lacasse A, Rey E, Ferreira E, Morin C, Berard A. Nausea and vomiting of pregnancy: what about quality of life? Bjog. 2008;115(12):1484\u201393.","journal-title":"Bjog."},{"key":"65_CR22","doi-asserted-by":"crossref","unstructured":"Miller F. Nausea and vomiting in pregnancy: the problem of perception\u2014is it really a disease? Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S182\u20133.","DOI":"10.1067\/mob.2002.122594"},{"issue":"1","key":"65_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/01674820109049946","volume":"22","author":"P Mazzotta","year":"2001","unstructured":"Mazzotta P, Stewart DE, Koren G, Magee LA. Factors associated with elective termination of pregnancy among Canadian and American women with nausea and vomiting of pregnancy. J Psychosom Obstet Gynaecol. 2001;22(1):7\u201312.","journal-title":"J Psychosom Obstet Gynaecol."},{"key":"65_CR24","doi-asserted-by":"crossref","unstructured":"Piwko C, Ungar WJ, Einarson TR, Wolpin J, Koren G. The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program. Curr Med Res Opin. 2007;23(4):833\u201340.","DOI":"10.1185\/030079907X178739"},{"issue":"2","key":"65_CR25","first-page":"10","volume":"20","author":"C Piwko","year":"2013","unstructured":"Piwko C, Koren G, Babashov V, Vicente C, Einarson TR. Economic burden of nausea and vomiting of pregnancy in the USA. J Popul Ther Clin Pharmacol. 2013;20(2):10.","journal-title":"J Popul Ther Clin Pharmacol."},{"issue":"11","key":"65_CR26","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1471-0528.1989.tb03229.x","volume":"96","author":"RM Weigel","year":"1989","unstructured":"Weigel RM, Weigel MM. Nausea and vomiting of early pregnancy and pregnancy outcome. A meta-analytical review. Br J Obstet Gynaecol. 1989;96(11):1312\u20138.","journal-title":"Br J Obstet Gynaecol."},{"issue":"1","key":"65_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jpeds.2009.02.005","volume":"155","author":"I Nulman","year":"2009","unstructured":"Nulman I, Rovet J, Barrera M, Knittel-Keren D, Feldman BM, Koren G. Long-term neurodevelopment of children exposed to maternal nausea and vomiting of pregnancy and Diclectin. J Pediatr. 2009;155(1):45\u201350.","journal-title":"J Pediatr."},{"issue":"11","key":"65_CR28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.2011.03023.x","volume":"118","author":"MV Veenendaal","year":"2011","unstructured":"Veenendaal MV, van Abeelen AF, Painter RC, van der Post JA, Roseboom TJ. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011;118(11):1302\u201313.","journal-title":"BJOG"},{"issue":"4","key":"65_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/humupd\/dmp009","volume":"15","author":"RH Oppenraaij van","year":"2009","unstructured":"van Oppenraaij RH, Jauniaux E, Christiansen OB, Horcajadas JA, Farquharson RG, Exalto N. Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Hum Reprod Update. 2009;15(4):409\u201321.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"65_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2011.01.010","volume":"156","author":"TJ Roseboom","year":"2011","unstructured":"Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2011;156(1):56\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"12","key":"65_CR31","first-page":"2109","volume":"53","author":"A Einarson","year":"2007","unstructured":"Einarson A, Maltepe C, Boskovic R, Koren G. Treatment of nausea and vomiting in pregnancy: an updated algorithm. Can Fam Physician. 2007;53(12):2109\u201311.","journal-title":"Can Fam Physician."},{"key":"65_CR32","doi-asserted-by":"crossref","unstructured":"Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2003;4:CD000145.","DOI":"10.1002\/14651858.CD000145"},{"issue":"1","key":"65_CR33","first-page":"76","volume":"76","author":"K Scorza","year":"2007","unstructured":"Scorza K, Williams A, Phillips JD, Shaw J. Evaluation of nausea and vomiting. Am Fam Physician. 2007;76(1):76\u201384.","journal-title":"Am Fam Physician."},{"issue":"6","key":"65_CR34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1517\/14740338.6.6.685","volume":"6","author":"SK Gill","year":"2007","unstructured":"Gill SK, Einarson A. The safety of drugs for the treatment of nausea and vomiting of pregnancy. Expert Opin Drug Saf. 2007;6(6):685\u201394.","journal-title":"Expert Opin Drug Saf."},{"issue":"4","key":"65_CR35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0890-6238(95)00020-B","volume":"9","author":"RL Brent","year":"1995","unstructured":"Brent RL. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen\u2013litigen. Reprod Toxicol. 1995;9(4):337\u201349.","journal-title":"Reprod Toxicol."},{"issue":"10","key":"65_CR36","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/106002808802201021","volume":"22","author":"TR Einarson","year":"1988","unstructured":"Einarson TR, Leeder JS, Koren G. A method for meta-analysis of epidemiological studies. Drug Intell Clin Pharm. 1988;22(10):813\u201324.","journal-title":"Drug Intell Clin Pharm."},{"issue":"1","key":"65_CR37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/tera.1420500105","volume":"50","author":"PM McKeigue","year":"1994","unstructured":"McKeigue PM, Lamm SH, Linn S, Kutcher JS. Bendectin and birth defects: I. A meta-analysis of the epidemiologic studies. Teratology. 1994;50(1):27\u201337.","journal-title":"Teratology"},{"key":"65_CR38","doi-asserted-by":"crossref","unstructured":"Magee LA, Mazzotta P, Koren G. Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S256\u201361.","DOI":"10.1067\/mob.2002.122596"},{"issue":"6","key":"65_CR39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajog.2010.07.030","volume":"203","author":"G Koren","year":"2010","unstructured":"Koren G, Clark S, Hankins GD, Caritis SN, Miodovnik M, Umans JG, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol. 2010;203(6):16.","journal-title":"Am J Obstet Gynecol."},{"key":"65_CR40","doi-asserted-by":"crossref","unstructured":"ACOG. ACOG (American College of Obstetrics and Gynecology) practice bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. 2004;103(4):803\u201314.","DOI":"10.1097\/00006250-200404000-00045"},{"key":"65_CR41","doi-asserted-by":"crossref","unstructured":"SOGC. Clinical practice guidelines. The management of nausea and vomiting of pregnancy. J Obstet Gynaecol Can. 2002;24(10):817\u201323.","DOI":"10.1016\/S1701-2163(16)30475-3"},{"key":"65_CR42","unstructured":"MothertoBaby. Nausea and vomiting. In: Maternal medical conditions fact sheets. http:\/\/www.mothertobaby.org\/files\/Nausea_and_Vomiting_7_13_2.pdf . 2013."},{"key":"65_CR43","unstructured":"http:\/\/www.bendectin.com . Accessed: October 01, 2013."},{"issue":"2","key":"65_CR44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/bdra.10021","volume":"67","author":"R Brent","year":"2003","unstructured":"Brent R. Bendectin and birth defects: hopefully, the final chapter. Birth Defects Res A Clin Mol Teratol. 2003;67(2):79\u201387.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"issue":"2","key":"65_CR45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/bdra.10034","volume":"67","author":"JS Kutcher","year":"2003","unstructured":"Kutcher JS, Engle A, Firth J, Lamm SH. Bendectin and birth defects. II: ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003;67(2):88\u201397.","journal-title":"Birth Defects Res A Clin Mol Teratol."},{"key":"65_CR46","unstructured":"Bendectin Peer Review Report 1975. Overall summary of 8-way Bendectin Study (unpublished study from the FDA databan DESI-10598). FDA1975 Contract No.: DESI 10598."},{"key":"65_CR47","doi-asserted-by":"crossref","unstructured":"Ornstein M, Einarson A, Koren G. Bendectin\/Diclectin for morning sickness: a Canadian follow-up of an American tragedy. Reprod Toxicol. 1995;9(1):1\u20136.","DOI":"10.1016\/0890-6238(94)00050-7"},{"key":"65_CR48","unstructured":"http:\/\/www.fda.gov\/OHRMS\/DOCKETS\/98fr\/080999e.pdf.Fr . Accessed: October 01, 2013."},{"issue":"1","key":"65_CR49","first-page":"66","volume":"86","author":"CI Neutel","year":"1995","unstructured":"Neutel CI, Johansen HL. Measuring drug effectiveness by default: the case of Bendectin. Can J Public Health. 1995;86(1):66\u201370.","journal-title":"Can J Public Health."},{"key":"65_CR50","unstructured":"Martindale: The complete drug reference. 37th ed. Database on the internet. London: Pharmaceutical Press; 2011."},{"key":"65_CR51","unstructured":"Ottawa TCPA. Compendium of pharmaceuticals and specialties. Ottawa, ON. 2013. http:\/\/www.pharmacists.ca\/index.cfm\/education-practice-resources\/canadian-drug-therapeutic-information\/errata\/errata-cps\/#cps2013 ."},{"issue":"3 Pt 1","key":"65_CR52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-9378(95)90359-3","volume":"173","author":"T Vutyavanich","year":"1995","unstructured":"Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995;173(3 Pt 1):881\u20134.","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"65_CR53","first-page":"33","volume":"78","author":"V Sahakian","year":"1991","unstructured":"Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol. 1991;78(1):33\u20136.","journal-title":"Obstet Gynecol."},{"key":"65_CR54","unstructured":"Serafin WE, Babe KS. H1-receptor antagonists. In: Gilman AG, Hardman JG, Limbird LE, et al., editors. The pharmacological basis of therapeutics. New York: McGraw-Hill Companies; 1996. p. 586\u2013692."},{"issue":"2","key":"65_CR55","first-page":"150","volume":"59","author":"G Koren","year":"2013","unstructured":"Koren G. Treating morning sickness PRN? Can Fam Physician. 2013;59(2):150\u20131.","journal-title":"Can Fam Physician."},{"key":"65_CR56","first-page":"78","volume-title":"Poisoning & drug overdose","author":"AS Tani","year":"1998","unstructured":"Tani AS. Antihistamines. In: Olson K, editor. Poisoning & drug overdose. Norwalk: Appletin&Lange; 1998. p. 78\u20139."},{"issue":"8","key":"65_CR57","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/00498258709044198","volume":"17","author":"DA Ganes","year":"1987","unstructured":"Ganes DA, Midha KK. Identification in in vivo acetylation pathway for N-dealkylated metabolites of doxylamine in humans. Xenobiotica. 1987;17(8):993\u20139.","journal-title":"Xenobiotica."},{"issue":"1","key":"65_CR58","first-page":"S43","volume":"51","author":"JF Gregory 3rd","year":"1997","unstructured":"Gregory JF 3rd. Bioavailability of vitamin B-6. Eur J Clin Nutr. 1997;51(1):S43\u20138.","journal-title":"Eur J Clin Nutr."},{"issue":"96","key":"65_CR59","first-page":"8","volume":"11","author":"T Mukherjee","year":"2011","unstructured":"Mukherjee T, Hanes J, Tews I, Ealick SE, Begley TP. Pyridoxal phosphate: biosynthesis and catabolism. Biochim Biophys Acta. 2011;11(96):8.","journal-title":"Biochim Biophys Acta."},{"key":"65_CR60","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2741\/e428","volume":"4","author":"ML Salvo di","year":"2012","unstructured":"di Salvo ML, Safo MK, Contestabile R. Biomedical aspects of pyridoxal 5\u2019-phosphate availability. Front Biosci. 2012;4:897\u2013913.","journal-title":"Front Biosci."},{"key":"65_CR61","unstructured":"Duchesnay Inc. Diclectin product monograph. Blainville, Quebec, Canada. 2013. p. 1\u201324."},{"issue":"3","key":"65_CR62","first-page":"29","volume":"16","author":"I Nulman","year":"2009","unstructured":"Nulman I, Koren G. Pharmacokinetic comparison of a delayed-release combination of doxylamine succinate and pyridoxine hydrocholoride (Diclectin) and oral solutions of these drugs in healthy women of childbearing age. Can J Clin Pharmacol. 2009;16(3):29.","journal-title":"Can J Clin Pharmacol."},{"issue":"1","key":"65_CR63","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/FTD.0b013e3181ff8bc5","volume":"33","author":"SK Gill","year":"2011","unstructured":"Gill SK, Garcia-Bournissen F, Koren G. Systemic bioavailability and pharmacokinetics of the doxylamine-pyridoxine delayed-release combination (Diclectin). Ther Drug Monit. 2011;33(1):115\u20139.","journal-title":"Ther Drug Monit."},{"issue":"10","key":"65_CR64","first-page":"184","volume":"30","author":"G Koren","year":"2013","unstructured":"Koren G, Vranderick M, Gill SK, Macleod S. Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate\u2013pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy. J Clin Pharmacol. 2013;30(10):184.","journal-title":"J Clin Pharmacol."},{"issue":"3","key":"65_CR65","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/0091270012445207","volume":"53","author":"I Matok","year":"2013","unstructured":"Matok I, Clark S, Caritis S, Miodovnik M, Umans J, Hankins G, et al. Comparing the pharmacokinetics of doxylamine\/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy. J Clin Pharmacol. 2013;53(3):334\u20138.","journal-title":"J Clin Pharmacol."},{"issue":"3","key":"65_CR66","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0890-6238(89)90007-5","volume":"3","author":"JM Rowland","year":"1989","unstructured":"Rowland JM, Slikker W Jr, Holder CL, Denton R, Prahalada S, Young JF, et al. Pharmacokinetics of doxylamine given as Bendectin in the pregnant monkey and baboon. Reprod Toxicol. 1989;3(3):197\u2013202.","journal-title":"Reprod Toxicol."},{"key":"65_CR67","first-page":"688","volume":"14","author":"CJ Geiger","year":"1959","unstructured":"Geiger CJ, Fahrenbach DM, Healey FJ. Bendectin in the treatment of nausea and vomiting in pregnancy. Obstet Gynecol. 1959;14:688\u201390.","journal-title":"Obstet Gynecol."},{"issue":"109","key":"65_CR68","first-page":"500","volume":"21","author":"BW McGuinness","year":"1971","unstructured":"McGuinness BW, Binns DT. \u2018Debendox\u2019 in pregnancy sickness. J R Coll Gen Pract. 1971;21(109):500\u20133.","journal-title":"J R Coll Gen Pract."},{"issue":"6","key":"65_CR69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1471-0528.1977.tb12620.x","volume":"84","author":"D Wheatley","year":"1977","unstructured":"Wheatley D. Treatment of pregnancy sickness. Br J Obstet Gynaecol. 1977;84(6):444\u20137.","journal-title":"Br J Obstet Gynaecol."},{"issue":"3","key":"65_CR70","first-page":"138","volume":"7","author":"R Bishai","year":"2000","unstructured":"Bishai R, Mazzotta P, Atanackovic G, Levichek Z, Pole M, Magee LA, et al. Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of Diclectin (doxylamine-B6). Can J Clin Pharmacol. 2000;7(3):138\u201343.","journal-title":"Can J Clin Pharmacol."},{"issue":"9","key":"65_CR71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1701-2163(16)34298-0","volume":"31","author":"N Ebrahimi","year":"2009","unstructured":"Ebrahimi N, Maltepe C, Bournissen FG, Koren G. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31(9):803\u20137.","journal-title":"J Obstet Gynaecol Can."},{"key":"65_CR72","unstructured":"Neutel I, Johansen HI. Variation in rates hospitalization for excessive vomiting in pregnancy by Bendectin\/Diclectin use in Canada. Nausea and vomiting of pregnancy. State of the art. Toronto: The Motherisk Program; 2000. p. 54\u20139."},{"issue":"371","key":"65_CR73","first-page":"245","volume":"43","author":"R Gadsby","year":"1993","unstructured":"Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43(371):245\u20138.","journal-title":"Br J Gen Pract."},{"issue":"10","key":"65_CR74","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1701-2163(16)30673-9","volume":"25","author":"R Boskovic","year":"2003","unstructured":"Boskovic R, Einarson A, Maltepe C, Wolpin J, Koren G. Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. J Obstet Gynaecol Can. 2003;25(10):830\u20133.","journal-title":"J Obstet Gynaecol Can."},{"issue":"8","key":"65_CR75","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1177\/00912700122010735","volume":"41","author":"G Atanackovic","year":"2001","unstructured":"Atanackovic G, Navioz Y, Moretti ME, Koren G. The safety of higher than standard dose of doxylamine\u2013pyridoxine (Diclectin) for nausea and vomiting of pregnancy. J Clin Pharmacol. 2001;41(8):842\u20135.","journal-title":"J Clin Pharmacol."},{"issue":"5","key":"65_CR76","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/FTD.0b013e31826e7997","volume":"34","author":"MM Costantine","year":"2012","unstructured":"Costantine MM, Matok I, Chiossi G, Clark S, Miodovnik M, Umans JG, et al. Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy. Ther Drug Monit. 2012;34(5):569\u201373.","journal-title":"Ther Drug Monit."},{"key":"65_CR77","doi-asserted-by":"crossref","first-page":"809787","DOI":"10.1155\/2013\/809787","volume":"2013","author":"C Maltepe","year":"2013","unstructured":"Maltepe C, Koren G. Preemptive treatment of nausea and vomiting of pregnancy: results of a randomized controlled trial. Obstet Gynecol Int. 2013;2013:809787. doi: 10.1155\/2013\/809787 .","journal-title":"Obstet Gynecol Int."},{"key":"65_CR78","doi-asserted-by":"crossref","unstructured":"Brent R. Medical, social, and legal implications of treating nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186(5 Suppl Understanding):S262\u20136.","DOI":"10.1067\/mob.2002.122603"},{"issue":"2","key":"65_CR79","first-page":"14","volume":"20","author":"G Koren","year":"2013","unstructured":"Koren G. The return to the USA of doxylamine-pyridoxine delayed release combination (Diclegis(R)) for morning sickness\u2013a new morning for American women. J Popul Ther Clin Pharmacol. 2013;20(2):14.","journal-title":"J Popul Ther Clin Pharmacol."},{"issue":"3","key":"65_CR80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0041-008X(68)90120-8","volume":"13","author":"JP Gibson","year":"1968","unstructured":"Gibson JP, Staples RE, Larson EJ, Kuhn WL, Holtkamp DE, Newberne JW. Teratology and reproduction studies with an antinauseant. Toxicol Appl Pharmacol. 1968;13(3):439\u201347.","journal-title":"Toxicol Appl Pharmacol."},{"issue":"2","key":"65_CR81","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/tera.1420320205","volume":"32","author":"AG Hendrickx","year":"1985","unstructured":"Hendrickx AG, Cukierski M, Prahalada S, Janos G, Rowland J. Evaluation of Bendectin embryotoxicity in nonhuman primates: I. Ventricular septal defects in prenatal macaques and baboon. Teratology. 1985;32(2):179\u201389.","journal-title":"Teratology."},{"key":"65_CR82","unstructured":"Briggs GG, Roger K. Freemen, Yaffe SJ. Drugs in pregnancy and lactation. 9th ed. Philadelphia: Lippincott Williams&Wilkins; 2011."},{"key":"65_CR83","unstructured":"Reprotox\u00ae database [electronic version] [homepage on the Internet] [database on the Internet]. 2013. Accessed: October 03, 2013."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-014-0065-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0065-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0065-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T20:23:40Z","timestamp":1565209420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-014-0065-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s40272-014-0065-5","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}